| CAS ID: | 254750-02-2 |
| Molecular Formula: | C26H27F4N3O7 |
| Molecular Weight: | 569.5 g/mol |
| Monoisotopic Mass: | 569.1785 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | IDN 6556 | PF 03491390 | EMRICASAN |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C26H27F4N3O7/c1-12(31-24(38)25(39)32-16-8-6-5-7-13(16)26(2,3)4)23(37)33-17(10-19(35)36)18(34)11-40-22-20(29)14(27)9-15(28)21(22)30/h5-9,12,17H,10-11H2,1-4H3,(H,31,38)(H,32,39)(H,33,37)(H,35,36)/t12-,17-/m0/s1 | See All |
| InChI Key: | SCVHJVCATBPIHN-SJCJKPOMSA-N | |
| Smiles: | C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc2c(F)c(F)cc(F)c2F | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02686762 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Active, not recruiting |
| First Received | February 19, 2016 | Last Verified | April 30, 2018 |
| Sponsor | Conatus Pharmaceuticals Inc. | ||
Trial Record 2
| ClinicalTrial ID | NCT02138253 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | May 14, 2014 | Last Verified | April 11, 2018 |
| Sponsor | Conatus Pharmaceuticals Inc. | ||
Trial Record 3
| ClinicalTrial ID | NCT03205345 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Active, not recruiting |
| First Received | July 2, 2017 | Last Verified | March 19, 2019 |
| Sponsor | Conatus Pharmaceuticals Inc. | ||
Trial Record 4
| ClinicalTrial ID | NCT02230670 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | September 3, 2014 | Last Verified | July 5, 2017 |
| Sponsor | Conatus Pharmaceuticals Inc. | ||
Trial Record 5
| ClinicalTrial ID | NCT02230683 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | September 3, 2014 | Last Verified | December 21, 2016 |
| Sponsor | Conatus Pharmaceuticals Inc. | ||
Trial Record 6
| ClinicalTrial ID | NCT02238444 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Recruiting |
| First Received | September 12, 2014 | Last Verified | January 1, 2019 |
| Sponsor | Yangzhou University | ||
Trial Record 7
| ClinicalTrial ID | NCT02960204 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Active, not recruiting |
| First Received | November 9, 2016 | Last Verified | April 30, 2018 |
| Sponsor | Conatus Pharmaceuticals Inc. | ||
Trial Record 8
| ClinicalTrial ID | NCT01937130 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | September 9, 2013 | Last Verified | April 11, 2016 |
| Sponsor | Conatus Pharmaceuticals Inc. | ||
| PubChem: | 12000240 |
| ChEMBL: | CHEMBL197672 |